Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response?
Smits
J F
JF
Cardiovascular Research Institute Maastricht, Department of Pharmacology, University of Limburg, The Netherlands.
Daemen
M J
MJ
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D006321:Heart / Q000187:drug effects*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000517:prevention & control; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D051381:Rats; D012084:Renin-Angiotensin System / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors